SGMT
UNKNOWNSagimet Biosciences Inc.
CIK: 0001400118
Sell
(70% confidence)
Last activity: 4 days ago
Financial Metrics
As of Dec 31, 2024 (10-K)
Net Income -$27.88M
Insider Roster (5 total, 5 active)
| Insider | Buys | Sells | Net Value | Holdings |
|---|---|---|---|---|
| Kemble George Executive Chairman | 0 | 1 | -$290K | 81,005 shares $623K |
| Happel David President & CEO | 0 | 1 | -$65K | 677,621 shares $3.63M |
| Martins Eduardo Bruno Chief Medical Officer | 0 | 1 | -$20K | 103,296 shares $554K |
| Rozek Elizabeth Chief Legal & Admin. Officer | 0 | 1 | -$14K | 190,959 shares $1.02M |
| Chauche Thierry Chief Financial Officer | 0 | 1 | -$7K | 15,688 shares $84K |
Recent Transactions
SELL Happel David (President & CEO)
12,101 shares @ $5.36
$65K
Feb 10, 2026
Conviction: |
View SEC Filing →
SELL Martins Eduardo Bruno (Chief Medical Officer)
3,640 shares @ $5.36
$20K
Feb 10, 2026
Conviction: |
View SEC Filing →
SELL Rozek Elizabeth (Chief Legal & Admin. Officer)
2,622 shares @ $5.36
$14K
Feb 10, 2026
Conviction: |
View SEC Filing →
SELL Chauche Thierry (Chief Financial Officer)
1,312 shares @ $5.36
$7K
Feb 10, 2026
Conviction: |
View SEC Filing →
SELL Kemble George (Executive Chairman)
37,688 shares @ $7.69
$290K
Nov 20, 2025
Conviction: |
View SEC Filing →
⚠️ Important Disclaimer
• This is AI-generated analysis for educational purposes only, not financial advice.
• Insider trading data is derived from SEC Form 4 filings and may contain errors.
• Always conduct your own research and consult qualified financial advisors before making investment decisions.